Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-II: Oral soft gel

Main Article Content

Ashutosh Mohapatra
Rajesh K Parikh
Mukesh C Gohel


Dionvenience of administration and patient compliance are gaining significant importance in the design of dosage forms. Metformin hydrochloride is an orally administered antihyperglycemic agent, used in the management of
non-insulin-dependant (type-2) diabetes mellitus. Difficulty in swallowing (dysphagia) is common among all age groups, especially in elderly and pediatrics. Unfortunately, a high percentage of patients suffering from type-2 diabetes are elderly people showing dysphagia. Persons suffering from dysphagia may get choked when they consume liquid formulation, thus to alleviate such problem liquid formulation of high viscosity was prepared. Formulation of oral soft gel batches of metformin was carried out using hydrophilic polymer gellan gum at concentrations ranging from 0.2-0.4% w/v and sodium citrate at
two different concentrations (0.3% and 0.5%). The prepared batches were evaluated for appearance, viscosity, pH, drug content, syneresis, in vitro drug release, and taste masking. The batch with 0.4% w/v gellan gum and 0.5% sodium citrate not only showed 85% drug release at 15 min, but all the desired organoleptic properties. The taste masking was carried out using nonnutritive sugar and flavors.The optimized batch showed substantial stability when subjected to short term stability study (0-8°C and Room temperature). The problem of dose measurement by patients was outweighed as oral medicated
gels are to be packed in unit dose container.


Download data is not yet available.

Article Details

How to Cite
Mohapatra, A., Parikh, R. K., & Gohel, M. C. (2014). Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-II: Oral soft gel. Asian Journal of Pharmaceutics (AJP), 2(3).


Wadhwani AR, Prabhu NB, Nandkarni MA, Amin PD. Consumer friendly

mucolytic formulations. Indian J Pharma Sci 2004;7:506-7.

Bhusan SY, Sambhaji SP, Anant RP, Kakasaheb RM. New drug delivery

system for elderly. Indian Drugs 2000;37:312-8.

Gohel MC, Bansal G, Bhatt N. Formulation and evaluation of

orodispersible taste masked tablets of Famotidine. Pharma Biol World


Hausler, Franz, Rohrich, Till. Effervescent Metformin composition and

tablets, granules there from, 2007, WO/ 038979 A1.

Yokoyama H, Hirata A, Hamamoto H, Ishibashi M, Yamasaki K, Fujii T.

Biguanide drug containing jelly preparation, 2007, U.S Patent app.,


Chandran R, Gogia A. liquid formulation of Metformin 2005. U.S Patent

No, 6,890,957 B2.

Ninomiya H, Shimizu T, Dairaku M, Komagata T. Jellied medicinal

composition for oral administration, 1999, U.S Patent No, 5,932,235.

Indian Pharmacopoeia. Vol. 2. New Delhi: Controller of Publication;

p. 555-6.

Morries JG, DeWille NT, Snowden GA, Chandler MA, Gunn AL,

Mulchandani RP, et al. Gellan gum to improve physical stability of

liquid nutritional products. 2000, US Patent: 6042854. Available from:

Sanderson GR, Clark RC. Gellan gum. Food Technol 1983;37:63-70.

Grasdalen H, Smidsrod O. Gelation of gellan gum. Carbohydrate

Polymers 1987;7:371-93.

Deasy PB, Quigley J. Rheological evaluation of deacylated gellan gum

(Gelrite) for pharmaceutical use. Int J Pharm 1991;73:117-23.

Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. 4th ed. London: Pharmaceutical Press; 2003. p. 560-2.

Itoh A, Niwas T. PCT Int. Appl WO 9830, 209 , through CA., 129